Metavention, Inc.

Developer of trans-catheter devices designed to modulate sympathetic nervous system activity. The company's devices treat over-active sympathetic nerves associated with elevated glucose and abnormal liver function while utilizing standard interventional vascular techniques to treat patients with Type 2 diabetes, enabling physicians and medical practitioners to acquire a new tool that can be effectively used in the diagnosis and subsequent treatment of patients suffering from type 2 diabetes.

New Enterprise Associates

🏥 Healthcare